𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized double-blind placebo-controlled dose-finding trial of intravenous immunoglobulin (octagam® 10%, octapharma AG) in patients with Alzheimer's disease

✍ Scribed by Farlow, Martin R.; Jessen, Frank; Wietek, Stefan; Melsen, Tina; Haag, Stefan; Dodel, Richard


Book ID
122870144
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
45 KB
Volume
6
Category
Article
ISSN
1552-5260

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


A double-blind, placebo-controlled singl
✍ Lisa Templeton; Andrew Barker; Keith Wesnes; David Wilkinson 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

Benzodiazepine agonists have been shown to reduce cognitive functioning by producing attentional de®cits similar to those produced by muscarinic antagonists. It has therefore been postulated that benzodiazepine antagonists may improve cognitive function in patients with Alzheimer's disease by indire